LYB
34
-2
ITW
33
2
LMT
29
7
LB
64
4
MCO
68
4
STI
10
-13
RSG
53
3
PNR
53
3
PWR
54
-3
MRK
30
-3
O
20
-8
HIG
48
4
CPB
22
-3
MSI
47
4
MHK
33
3
CLX
68
2
BSX
73
4
CNX
49
7
UAL
77
5
BLK
46
2
LYB
34
-2
ITW
33
2
LMT
29
7
LB
64
4
MCO
68
4
STI
10
-13
RSG
53
3
PNR
53
3
PWR
54
-3
MRK
30
-3
O
20
-8
HIG
48
4
CPB
22
-3
MSI
47
4
MHK
33
3
CLX
68
2
BSX
73
4
CNX
49
7
UAL
77
5
BLK
46
2
Financhill
Back

Glanbia PLC Vs. Janux Therapeutics Industry Stock Comparison

Sell
32

GLAPF
Glanbia PLC

Last Price:
$13.83
Seasonality Move:
5.92%
Sell
23

JANX
Janux Therapeutics

Last Price:
$50.53
Seasonality Move:
80.32%
Sell
32
Glanbia PLC (GLAPF) is a Sell

Is Glanbia PLC a Buy, Sell or Hold?

  • The current Glanbia PLC [GLAPF] share price is $13.83. The Score for GLAPF is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • GLAPF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GLAPF Stock Price Chart

What is Glanbia PLC's stock price today?

  • The Glanbia PLC share price today is $13.83
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLAPF is experiencing selling pressure, which indicates risk of future bearish movement.

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $50.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

GLAPF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.34 Sell
Relative Strength Index (14 RSI): 36.51 Sell
Chaikin Money Flow: -862 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.21 - 15.27) Sell
Bollinger Bands (100): (15.21 - 18.21) Sell

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 41.88 Sell
Chaikin Money Flow: -1994706 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 62.68) Sell
Bollinger Bands (100): (44.76 - 56.7) Buy

GLAPF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.18 Sell
20-day SMA: 14.55 Sell
50-day SMA: 15.41 Sell
200-day SMA: 17.89 Sell
8-day EMA: 14.33 Sell
20-day EMA: 14.59 Sell
50-day EMA: 15.39 Sell
200-day EMA: 16.92 Sell

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.68 Sell
20-day SMA: 56.78 Sell
50-day SMA: 54.64 Sell
200-day SMA: 47.7 Buy
8-day EMA: 54.12 Sell
20-day EMA: 55.17 Sell
50-day EMA: 54.12 Sell
200-day EMA: 45.19 Buy

Glanbia PLC Earnings Growth & GLAPF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.

Glanbia PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):